Skip to main content
Contact Us
Subscribe
E-Edition
56°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Celsion Corp
(NQ:
CLSN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 20, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.900 (5)
Ask (Size)
2.100 (31)
Prev. Close
1.960
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
14,500,685
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
Via
Benzinga
Celsion Earnings Perspective: Return On Capital Employed
September 09, 2022
According to Benzinga Pro data, during Q2, Celsion (NASDAQ:CLSN) posted sales of $125 thousand. Earnings were up 42.31%, but Celsion still reported an overall loss of $6.04 million.
Via
Benzinga
Performance
More News
Read More
Recap: Celsion Q2 Earnings
August 15, 2022
Via
Benzinga
Earnings Outlook For Celsion
August 12, 2022
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Via
Benzinga
Celsion: Q1 Earnings Insights
May 16, 2022
Via
Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Via
Benzinga
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression
May 18, 2022
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Earnings Outlook For Celsion
May 13, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 21, 2022
Via
Benzinga
Celsion's Formulated DNA Plasmid COVID-19 Vaccine Candidate Shows Activity Against Two Strains
April 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 20, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
April 13, 2022
Via
Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Via
Benzinga
53 Biggest Movers From Yesterday
April 08, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 07, 2022
Via
Benzinga
51 Biggest Movers From Yesterday
April 07, 2022
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Down 5%; Celsion Shares Plummet
April 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 06, 2022
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
April 06, 2022
Via
Benzinga
Why Celsion Shares Are Pulling Back Today
April 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 06, 2022
Via
Benzinga
51 Biggest Movers From Yesterday
April 06, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
